KAILIAN VAUGHN M

Director at CEPHALON INC · on record since May 19, 2006
Director at MEMORY PHARMACEUTICALS CORP · on record since Oct 18, 2006
10% owner at MEMORY PHARMACEUTICALS CORP · on record since Oct 18, 2006
President and CEO at MEMORY PHARMACEUTICALS CORP · on record since Feb 12, 2008
10% owner at PEPLIN INC · on record since Oct 30, 2008
Director at MILLENNIUM PHARMACEUTICALS INC · on record since Sep 3, 2003
Vice Chairperson at MILLENNIUM PHARMACEUTICALS INC · on record since Sep 3, 2003
10% owner at Pacira Pharmaceuticals, Inc. · on record since Feb 17, 2011
10% owner at MPM ACQUISITION CORP · on record since May 19, 2011
Former 10% stockholder at Verastem, Inc. · on record since Feb 3, 2012
Former 10% Owner at Pacira Pharmaceuticals, Inc. · on record since Mar 13, 2013
10% owner at Epizyme, Inc. · on record since May 30, 2013
10% owner at ARATANA THERAPEUTICS, INC. · on record since Jun 26, 2013
10% owner at Conatus Pharmaceuticals Inc · on record since Jul 24, 2013
10% owner at TriVascular Technologies, Inc. · on record since Apr 23, 2014
10% owner at CHIASMA, INC · on record since Jul 21, 2015
10% owner at ADVANCE TECHNOLOGIES INC · on record since Oct 20, 2015
10% owner at Syndax Pharmaceuticals Inc · on record since Mar 9, 2016
Former 10% stockholder at MPM ACQUISITION CORP · on record since Sep 29, 2016
Director at · on record since Jan 19, 2005

Insider trading activity of KAILIAN VAUGHN M

Transactions on record: 36; since Sep 3, 2003

Open-market buys: 1; $1M

Open-market sells: 6; $27.9M

Companies traded: 6; last filing Mar 12, 2014

Figures computed from official regulatory filings — .

Companies where KAILIAN VAUGHN M has traded

1 tx · $12M · Mar 12, 2014
1 tx · $13.9M · Mar 13, 2013
5 tx · $1M · Feb 3, 2012
14 tx · Oct 17, 2011
6 tx · $211.4K · Feb 12, 2008
9 tx · $2.2M · Jul 2, 2004

Track record of KAILIAN VAUGHN M

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of KAILIAN VAUGHN M

Co-insiders of KAILIAN VAUGHN M

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
ARATANA THERAPEUTICS, INC.	Mar 12, 2014	Sell	-600,000	20.02 USD	$12M	SEC
Pacira Pharmaceuticals, Inc.	Mar 13, 2013	Sell	-500,000	27.86 USD	$13.9M	SEC
Verastem, Inc.	Feb 3, 2012	OtherD (derivative)	-266,666	0.00 USD	—	SEC
Verastem, Inc.	Feb 3, 2012	OtherD (derivative)	-2,500,000	0.00 USD	—	SEC
Verastem, Inc.	Feb 3, 2012	OtherD (derivative)	-4,000,000	0.00 USD	—	SEC
Verastem, Inc.	Feb 3, 2012	Other	1,933,333	—	—	SEC
Verastem, Inc.	Feb 3, 2012	Buy	100,000	10.00 USD	$1M	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-15,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-10,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-15,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-10,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-10,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-15,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-10,000	—	—	SEC
CEPHALON INC	May 12, 2011	AwardD (derivative)	15,000	0.00 USD	—	SEC
CEPHALON INC	May 21, 2010	AwardD (derivative)	15,000	0.00	—	SEC
CEPHALON INC	May 14, 2009	AwardD (derivative)	10,000	0.00	—	SEC
CEPHALON INC	May 27, 2008	AwardD (derivative)	10,000	0.00	—	SEC
MEMORY PHARMACEUTICALS CORP	Feb 12, 2008	AwardD (derivative)	363,630	0.00	—	SEC
MEMORY PHARMACEUTICALS CORP	Sep 18, 2007	Sell	-27,600	2.10	$58K	SEC
MEMORY PHARMACEUTICALS CORP	Sep 14, 2007	Sell	-62,180	2.12	$131.8K	SEC
MEMORY PHARMACEUTICALS CORP	Sep 14, 2007	Sell	-10,000	2.16	$21.6K	SEC
MEMORY PHARMACEUTICALS CORP	Jul 20, 2007	AwardD (derivative)	10,000	0.00	—	SEC
CEPHALON INC	May 17, 2007	AwardD (derivative)	10,000	0.00	—	SEC
MEMORY PHARMACEUTICALS CORP	Oct 18, 2006	AwardD (derivative)	20,000	0.00	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ARATANA THERAPEUTICS, INC.	Mar 12, 2014	Sell	-600,000	20.02 USD	$12M	SEC
Pacira Pharmaceuticals, Inc.	Mar 13, 2013	Sell	-500,000	27.86 USD	$13.9M	SEC
Verastem, Inc.	Feb 3, 2012	OtherD (derivative)	-266,666	0.00 USD	—	SEC
Verastem, Inc.	Feb 3, 2012	OtherD (derivative)	-2,500,000	0.00 USD	—	SEC
Verastem, Inc.	Feb 3, 2012	OtherD (derivative)	-4,000,000	0.00 USD	—	SEC
Verastem, Inc.	Feb 3, 2012	Other	1,933,333	—	—	SEC
Verastem, Inc.	Feb 3, 2012	Buy	100,000	10.00 USD	$1M	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-15,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-10,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-15,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-10,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-10,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-15,000	—	—	SEC
CEPHALON INC	Oct 17, 2011	OtherD (derivative)	-10,000	—	—	SEC
CEPHALON INC	May 12, 2011	AwardD (derivative)	15,000	0.00 USD	—	SEC
CEPHALON INC	May 21, 2010	AwardD (derivative)	15,000	0.00	—	SEC
CEPHALON INC	May 14, 2009	AwardD (derivative)	10,000	0.00	—	SEC
CEPHALON INC	May 27, 2008	AwardD (derivative)	10,000	0.00	—	SEC
MEMORY PHARMACEUTICALS CORP	Feb 12, 2008	AwardD (derivative)	363,630	0.00	—	SEC
MEMORY PHARMACEUTICALS CORP	Sep 18, 2007	Sell	-27,600	2.10	$58K	SEC
MEMORY PHARMACEUTICALS CORP	Sep 14, 2007	Sell	-62,180	2.12	$131.8K	SEC
MEMORY PHARMACEUTICALS CORP	Sep 14, 2007	Sell	-10,000	2.16	$21.6K	SEC
MEMORY PHARMACEUTICALS CORP	Jul 20, 2007	AwardD (derivative)	10,000	0.00	—	SEC
CEPHALON INC	May 17, 2007	AwardD (derivative)	10,000	0.00	—	SEC
MEMORY PHARMACEUTICALS CORP	Oct 18, 2006	AwardD (derivative)	20,000	0.00	—	SEC